ActualEyes
Developer of regenerative drugs and eye drops intended to treat Fuchs corneal endothelial dystrophy. The company offers a combination of cultured human corneal endothelial cells and an inhibitor for t...
Valuation
$0
Share Price
N/A
Total Raised
$9.9M
Last Round
N/A